» Articles » PMID: 34988090

Treatment of Inflammatory Bowel Disease: A Comprehensive Review

Overview
Specialty General Medicine
Date 2022 Jan 6
PMID 34988090
Citations 181
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammatory bowel disease (IBD), as a global disease, has attracted much research interest. Constant research has led to a better understanding of the disease condition and further promoted its management. We here reviewed the conventional and the novel drugs and therapies, as well as the potential ones, which have shown promise in preclinical studies and are likely to be effective future therapies. The conventional treatments aim at controlling symptoms through pharmacotherapy, including aminosalicylates, corticosteroids, immunomodulators, and biologics, with other general measures and/or surgical resection if necessary. However, a considerable fraction of patients do not respond to available treatments or lose response, which calls for new therapeutic strategies. Diverse therapeutic options are emerging, involving small molecules, apheresis therapy, improved intestinal microecology, cell therapy, and exosome therapy. In addition, patient education partly upgrades the efficacy of IBD treatment. Recent advances in the management of IBD have led to a paradigm shift in the treatment goals, from targeting symptom-free daily life to shooting for mucosal healing. In this review, the latest progress in IBD treatment is summarized to understand the advantages, pitfalls, and research prospects of different drugs and therapies and to provide a basis for the clinical decision and further research of IBD.

Citing Articles

Combining mechanistic modeling with machine learning as a strategy to predict inflammatory bowel disease clinical scores.

Shim J, Rehberg M, Wagenhuber B, van der Graaf P, Chung D Front Pharmacol. 2025; 16:1479666.

PMID: 40070575 PMC: 11893853. DOI: 10.3389/fphar.2025.1479666.


Using gut microbiota and non-targeted metabolomics techniques to study the effect of xylitol on alleviating DSS-induced inflammatory bowel disease in mice.

Ma P, Sun W, Sun C, Tan J, Dong X, He J BMC Immunol. 2025; 26(1):18.

PMID: 40065221 PMC: 11892251. DOI: 10.1186/s12865-025-00700-z.


Inflammatory Bowel Disease in Children: Current Diagnosis and Treatment Strategies.

Bhalla A, Shahi A, Maity M, Safa F, Srividya V, Clementina R Cureus. 2025; 17(2):e78462.

PMID: 40051947 PMC: 11883196. DOI: 10.7759/cureus.78462.


Investigating the expression of anti/pro-inflammatory cytokines in the pathogenesis and treatment of ulcerative colitis and its association with serum level of vitamin D.

Ahmadi A, Yousefimashouf R, Mohammadi A, Nikkhoo B, Shokoohizadeh L, Khan Mirzaei M Sci Rep. 2025; 15(1):7569.

PMID: 40038357 PMC: 11880460. DOI: 10.1038/s41598-025-87551-1.


Apical periodontitis in inflammatory bowel disease: a meta-analysis at patient and tooth level.

La Rosa G, Lorenzo-Pouso A, Caponio V, Puci M Front Dent Med. 2025; 6:1553914.

PMID: 40008255 PMC: 11847799. DOI: 10.3389/fdmed.2025.1553914.


References
1.
Boussen I, Sokol H, Aractingi S, Georges O, Hoyeau-Idrissi N, Hugot J . Inflammatory bowel disease after allogeneic stem cell transplantation. Bone Marrow Transplant. 2015; 50(10):1365-6. DOI: 10.1038/bmt.2015.138. View

2.
Rossen N, Fuentes S, van der Spek M, Tijssen J, Hartman J, Duflou A . Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis. Gastroenterology. 2015; 149(1):110-118.e4. DOI: 10.1053/j.gastro.2015.03.045. View

3.
Neurath M . IL-23: a master regulator in Crohn disease. Nat Med. 2007; 13(1):26-8. DOI: 10.1038/nm0107-26. View

4.
Rutgeerts P, Gasink C, Chan D, Lang Y, Pollack P, Colombel J . Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease. Gastroenterology. 2018; 155(4):1045-1058. DOI: 10.1053/j.gastro.2018.06.035. View

5.
McSharry K, Dalzell A, Leiper K, El-Matary W . Systematic review: the role of tacrolimus in the management of Crohn's disease. Aliment Pharmacol Ther. 2011; 34(11-12):1282-94. DOI: 10.1111/j.1365-2036.2011.04873.x. View